Market Overview

Acacia Subsidiary Acquires Vascular Device Technology Patents


Acacia Research Corporation (NASDAQ: ACTG) announced today that a
subsidiary has acquired patents relating to vascular device technology.

“Acacia and its subsidiaries continue to increase the number of patent
portfolios they control in the medical device and diagnostics sectors,”
commented Paul Ryan, CEO.

See full press release

Posted-In: News Guidance M&A


Related Articles (ACTG)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→